In the US, Mefoxin (cefoxitin systemic) is a member of the drug class second generation cephalosporins and is used to treat Aspiration Pneumonia, Bone infection, Cesarean Section, Cholecystitis, Deep Neck Infection, Endometritis, Gonococcal Infection - Uncomplicated, Intraabdominal Infection, Joint Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Septicemia, Skin and Structure Infection, Skin Infection, Surgical Prophylaxis and Urinary Tract Infection.
US matches:
Ingredient matches for Mefoxin
Cefoxitin
Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of Mefoxin in the following countries:
- Argentina
- Bahrain
- Cyprus
- Egypt
- Guyana
- Iran
- Iraq
- Ireland
- Italy
- Jordan
- Kuwait
- Lebanon
- Luxembourg
- Oman
- Qatar
- Saudi Arabia
- Sudan
- Syria
- Taiwan
- United Arab Emirates
- United States
- Yemen
International Drug Name Search